alexa The Duchenne Muscular Dystrophy: Pathology Regression After Stem Cell Treatment
ISSN: 2157-7633

Journal of Stem Cell Research & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

6th International Conference and Exhibition on Cell and Gene Therapy
March 27-28, 2017 Madrid, Spain

Decio Basso
Universidad Privada Del Este, Paraguay
ScientificTracks Abstracts: J Stem Cell Res Ther
DOI: 10.4172/2157-7633.C1.023
Abstract
The Duchenne Muscular Dystrophy (DMD) is a progressive degeneration of the striated muscles of the body. It is caused by a genetic defect that prevents the production of a protein called dystrophin. DMD is the most common form of neurodegenerative disease. At the cellular level, this can be explained as muscle necrosis that exceeds the regenerative capacity of muscles. To endure the severities of every muscle contraction, muscle fibers have specialized cytoskeletal protein complexes, dystrophin. These complexes make it possible for myocytes to endure mechanical stress of the muscle contraction. In DMD, abnormalities in the dystrophin gene lead to non-expression of the protein, dystrophin. The lack of dystrophin causes the muscles to become fragile and easily damaged. Over time, the degeneration is such that the body cannot repair and muscles degenerate, causing disability in patients. The main strategies based on stem cells are: 1. Generate healthy muscle fibers; if stem cell implant in the muscles of the affected patients is made, they may generate functional muscle fibers that replace the damaged ones, 2. Reducing Inflammation: The muscles damaged by muscular dystrophy suffer a lot of inflammation. Inflammation process accelerates muscle degeneration. Certain types of stem cells can liberate chemical agents that reduce inflammation by reducing disease progression. In this clinical case, the patient (female) arrived in the clinic diagnosed as DMD. Treatment proposed with Stem Cell Implant (Mesenchymal Autologous): Stem cells are implanted through the release of growth factors and the act of vascular stromal cells to prevent the death of motor neurons. They feed the motor neurons or make them healthier, slow the degenerative process and reduce inflammation.
Biography

Decio Basso headed the Federal University Santa Catarina at Florianópolis - Brazil where he earned a Medical Degree. He then attended Pontifical Catholic University of Rio Grande do Sul - Brasil to pursue a specialization Medical Degree in Geriatric and Gerontology. After graduation, he accepted an internship, continuing education at Harvard Medical School in Boston, USA. He has been an integral part of Medical Staff at The Department of Immunology at the University of British Columbia – MBvax Canadá. He is serving as a Professor at Universidad Privada Del Este, Paraguay. He launched his own medical research organization known as the Gerobasso Medical Research Center. He is also a member of the scientific committee SOLCEMA (Sociedad Latinoamericana Stem Cell).

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords